IVGN

Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems - 08/25 - 07:00 AM ET

Invitrogen Launches Legionella Test to Streamline Surveillance - 08/19 - 08:00 AM ET

IVGN touches 200-day moving average at 43.81 - 08/12 - 02:00 AM ET

Fitch Rates Invitrogen Corp. 'BBB-'; Outlook Stable - 08/04 - 01:20 PM ET

Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression - 08/04 - 08:00 AM ET

IVGN touches 200-day moving average at 43.86 - 08/01 - 11:53 AM ET

Invitrogen Licenses Stem Cell Line from Buck Institute - 07/30 - 04:03 PM ET

Invitrogen Announces Second Quarter 2008 Financial Results - 07/24 - 08:30 AM ET

Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis - 07/21 - 01:00 AM ET

Invitrogen Corporation (IVGN) Corporate Event Announcement Notice - 07/10 - 09:04 PM ET

Invitrogen Corporation (IVGN) Corporate Event Announcement Notice - 07/09 - 09:01 PM ET

Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008 - 07/08 - 08:13 PM ET

FDA Grants Invitrogen Premarket Approval of Breast Cancer Test - 07/08 - 09:13 AM ET

Invitrogen Corporation (IVGN) Corporate Event Announcement Notice - 07/03 - 08:58 PM ET

Invitrogen Corporation (IVGN) Corporate Event Announcement Notice - 07/02 - 09:02 PM ET

Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to Advance Pharmacogenomics Research - 06/30 - 04:03 PM ET

Invitrogen Advances Drug Discovery Safety Testing - 06/24 - 04:03 PM ET

Invitrogen (IVGN) NewsBite - Invitrogen Down on Economy Concerns - 06/24 - 03:28 AM ET

Invitrogen Foundation Celebrates First Grant-Giving Programs - 06/18 - 11:52 PM ET

Invitrogen Partners With International Regulome Consortium to Advance Stem Cell Research for the Development of Life Saving Therapies - 06/18 - 05:08 PM ET

Page 1 of 9     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index